First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.

Wang, Liang; Wang, Zhi-hui; Chen, Xiao-qin; Li, Ya-jun; Wang, Ke-feng; Xia, Yun-fei; Xia, Zhong-jun

Wang, Liang; Wang, Zhi-hui; Chen, Xiao-qin; Li, Ya-jun; Wang, Ke-feng; Xia, Yun-fei; Xia, Zhong-jun.

Affiliation

Wang L; Department of Hematological Oncology. Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

Cancer ; 119(2): 348-55, 2013 Jan 15.

Article in En | MEDLINE | ID: mdl-22811078

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Head and Neck Neoplasms/therapy; Induction Chemotherapy; Lymphoma, Extranodal NK-T-Cell/therapy; Adult; Aged; Aluminum Hydroxide/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bentonite/administration & dosage; Chemoradiotherapy; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease-Free Survival; Drug Combinations; Female; Head and Neck Neoplasms/mortality; Head and Neck Neoplasms/pathology; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell/mortality; Lymphoma, Extranodal NK-T-Cell/pathology; Magnesium Hydroxide/administration & dosage; Male; Middle Aged; Neoplasm Recurrence, Local/prevention & control; Neoplasm Staging; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Prospective Studies; Treatment Outcome; Young Adult; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Extranodal NK-T-Cell / Induction Chemotherapy / Head and Neck Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google